Loading…
Surrozen, Inc. is projected to rise to $38.67 by 2027, a +46% move from its current price of $26.46. SRZN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $25.53 | $26.49 | $27.48 | +0.10% |
| May 30 | $25.17 | $26.51 | $27.93 | +0.20% |
| May 31 | $24.90 | $26.54 | $28.28 | +0.31% |
| Jun 1 | $24.69 | $26.57 | $28.59 | +0.41% |
| Jun 2 | $24.50 | $26.59 | $28.87 | +0.51% |
| Jun 3 | $24.33 | $26.62 | $29.13 | +0.61% |
| Jun 4 | $24.18 | $26.65 | $29.37 | +0.71% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $24.18 | $26.65 | $29.37 | +0.71% |
| Week 2 | $23.39 | $26.84 | $30.79 | +1.43% |
| Week 3 | $22.84 | $27.03 | $31.99 | +2.16% |
| Week 4 | $22.41 | $27.22 | $33.06 | +2.88% |
| Week 5 | $22.06 | $27.42 | $34.07 | +3.62% |
| Week 6 | $21.76 | $27.61 | $35.04 | +4.36% |
| Week 7 | $21.50 | $27.81 | $35.97 | +5.10% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Surrozen, Inc. is a biotechnology company that discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair.
Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the eye, intestine, liver, lung, retina, kidney, cochlea, cornea, skin, pancreas, and central nervous system.
Surrozen develops SZN-814, which combines Frizzled 4 (Fzd4 agonism) and vascular endothelial growth factor (VEGF antagonism) to treat diabetic macular edema (DME), neovascular age-related macular degeneration (wet AMD), and retinopathy indications; SZN-8143, which combines Fzd4 agonism, VEGF antagonism, and interleukin-6, or IL-6 for the treatment of DME/wet AMD/uveitic macular edema; and SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases.
Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California.
Surrozen, Inc. is a biotechnology company that discovers and develops product candidates to modulate the Wnt pathway for tissue repair.
The current price is $26.37, the market cap is $306.17M, and the stock ranks 3513.
The year-by-year forecast shows a bullish trajectory across multiple years, with the 2026 average price at $26.37, rising to $55.28 in 2030 and $412.60 by 2050, along with correspondingly rising ROI figures (0% in 2026, 109.6% in 2030, 1464.6% in 2050) and bullish sentiment in the later years.
A major floor 32.0% below — a decisive break under it would weaken the trend.
The nearest floor, 3.4% below — buyers have tended to step in here.
The nearest ceiling, 29.0% above — a clean break opens room to run.
A major ceiling 40.9% above — clearing it would confirm fresh momentum.
Key SRZN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SRZN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $26.63 | Sell | $26.65 | Sell |
| MA 10 | $27.43 | Sell | $27.43 | Sell |
| MA 20 | $29.57 | Sell | $28.46 | Sell |
| MA 50 | $28.94 | Sell | $28.38 | Sell |
| MA 100 | $26.16 | Buy | $26.11 | Buy |
| MA 200 | $20.35 | Buy | $22.03 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 41.47 | Neutral |
| Stoch RSI (14) | 30.75 | Neutral |
| CCI (20) | -89.54 | Neutral |
| Williams %R (14) | -82.82 | Info |
| MACD (12,26,9) | -0.50 | Sell |
| ROC (12) | -8.63 | Sell |
| Bollinger %B (20,2) | 0.21 | Neutral |
| Stochastic %K (14) | 17.18 | Buy |
| TRIX (15) | -0.21 | Sell |
| Awesome (5,34) | -3.33 | Sell |
| Ultimate (7,14,28) | 32.63 | Neutral |
| Momentum (10) | -4.20 | Sell |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 26.12 | Buy |
| ADX (14) | 14.49 | Neutral |
| ATR (14) | 1.01 | Info |
The 30-day technical picture is bullish overall.
RSI14 is 40, while the short-term trend is supported by a SMA50 of $28.90 and a SMA200 of $20.18. The immediate support is at $25.57 and resistance at $34.13.
The thirty-day price range spans from $20.39 to $34.10, and the stock carries an annualized volatility of 70%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $17.98 | $26.46 | $39.73 | 0% | Neutral | |
| $29.64 | $38.67 | $54.00 | +46% | Bullish | |
| $34.46 | $46.69 | $68.25 | +76% | Bullish | |
| $33.20 | $46.46 | $70.39 | +76% | Bullish | |
| $38.96 | $56.11 | $87.60 | +112% | Bullish | |
| $47.44 | $70.15 | $112.45 | +165% | Bullish | |
| $58.30 | $88.38 | $145.02 | +234% | Bullish | |
| $73.41 | $113.95 | $190.98 | +331% | Bullish | |
| $73.63 | $116.90 | $199.78 | +342% | Bullish | |
| $75.65 | $122.75 | $213.58 | +364% | Bullish | |
| $134.19 | $240.89 | $451.74 | +810% | Bullish | |
| $196.16 | $422.97 | $883.37 | +15.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $17.98 | $26.46 | $31.37 | +0.00% |
| June 2026 | $23.94 | $28.33 | $34.47 | +7.05% |
| July 2026 | $24.25 | $29.03 | $35.96 | +2.48% |
| August 2026 | $23.63 | $28.54 | $35.84 | -1.68% |
| September 2026 | $24.05 | $29.26 | $37.16 | +2.52% |
| October 2026 | $24.92 | $30.52 | $39.15 | +4.31% |
| November 2026 | $24.61 | $30.33 | $39.24 | -0.62% |
| December 2026 | $24.57 | $30.45 | $39.73 | +0.41% |
Click any year to see its month-by-month SRZN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Surrozen, Inc.'s 2026 outlook centres on $26.46, within a $17.98 to $39.73 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, SRZN could reach as high as $54.00, with a base case around $38.67 and support toward $29.64 — roughly +46% from $26.46. Buyers look set to stay in control over this stretch.
Expect SRZN to range from $34.46 to $68.25 through 2028. The $46.69 average target implies a +76% move from current prices. That is up +21% on the projected 2027 average. Momentum favours further upside here.
The SRZN price prediction for 2029 points to an average of $46.46 (low $33.20, high $70.39) — a potential gain of +76% on today's $26.46. Buyers look set to stay in control over this stretch.
In 2030, SRZN is projected to trade between $38.96 and $87.60, averaging $56.11 — a potential gain of +112% from today's $26.46. That is up +21% on the projected 2029 average. Momentum favours further upside here.
Surrozen, Inc.'s 2031 outlook centres on $70.15, within a $47.44 to $112.45 range. That is up +25% on the projected 2030 average. That marks a +165% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, SRZN could reach as high as $145.02, with a base case around $88.38 and support toward $58.30 — roughly +234% from $26.46. Momentum favours further upside here.
Expect SRZN to range from $73.41 to $190.98 through 2033. The $113.95 average target implies a +331% move from current prices. That is up +29% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The SRZN price prediction for 2034 points to an average of $116.90 (low $73.63, high $199.78) — a potential gain of +342% on today's $26.46. Momentum favours further upside here.
In 2035, SRZN is projected to trade between $75.65 and $213.58, averaging $122.75 — a potential gain of +364% from today's $26.46. That is up +5% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Surrozen, Inc.'s 2040 outlook centres on $240.89, within a $134.19 to $451.74 range. That is up +96% on the projected 2035 average. That marks a +810% change versus current levels. Momentum favours further upside here.
By 2050, SRZN could reach as high as $883.37, with a base case around $422.97 and support toward $196.16 — roughly +15.0x from $26.46. Buyers look set to stay in control over this stretch.
Investing $1,000 in SRZN today (≈ 37.792895 SRZN) could be worth
$15,985.15
+$14,985.15 (+1499%) by 2050 · US Dollar
Based on the average projected SRZN price of $422.97 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SRZNwould be worth at today's price.
$1,000 invested in SRZN on May 27, 2025 (≈ 130.718953 SRZN) would be worth
$3,458.82
+$2,458.82 (+245.9%) today · 3.46× · US Dollar
Based on a SRZN entry price of $7.65 vs. today's $26.46.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $27.05 | $978.19 | -2.2% |
| 1 month ago | $29.95 | $883.47 | -11.7% |
| 3 months ago | $25.75 | $1,027.57 | +2.8% |
| 6 months ago | $16.58 | $1,595.9 | +59.6% |
| 1 year ago | $7.65 | $3,458.82 | +245.9% |
| All time (5.0y) ago | $147.75 | $179.09 | -82.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SRZN forecast.
Our base-case forecast reaches $53.00 around 2030.
Implied market cap at $53.00: $615.35M
The multi-year forecast depicts a continuing upward path, with a 2030 average price of $55.28 and a 2030 max of $87.71 (min $37.77) and a 109.6% ROI, all within a bullish sentiment framework.
Looking further out, the 2040 forecast shows an average of $235.62 with a 793.5% ROI, maintaining the bullish stance.
By 2050, the average is projected at $412.60 with a 1464.6% ROI, sustaining a bullish outlook across the long horizon.
These figures are estimates and not guarantees, but they illustrate a path of substantial upside if the forecast proves accurate.
Tap a question to reveal the answer.
The forecast lists year 2030 avg $55.28 with min $37.77 and max $87.71; ROI 109.6%; sentiment BULLISH.
The forecast shows a neutral stance in 2026 and bullish sentiment in subsequent years, with 2027 avg $38.79 and 2030 avg $55.28, rising to 2040 avg $235.62 and 2050 avg $412.60; ROI milestones include 47.1% in 2027, 109.6% in 2030, 793.5% in 2040, and 1464.6% in 2050.
Yes. The forecast indicates 2032 avg $87.68 and 2033 avg $113.29, suggesting an average price above $100 by 2033, with a range up to $193.54 in 2033.
The thirty-day range is $20.39 to $34.10.
The current price is $26.37 and the market cap is $306.17M.
Surrozen, Inc. Community Discussion
0Share your Surrozen, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.